1
|
Synthesis, LC-MS/MS analysis, and biological evaluation of two vaccine candidates against ticks based on the antigenic P0 peptide from R. sanguineus linked to the p64K carrier protein from Neisseria meningitidis. Anal Bioanal Chem 2021; 413:5885-5900. [PMID: 34341841 PMCID: PMC8328535 DOI: 10.1007/s00216-021-03569-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2021] [Revised: 07/12/2021] [Accepted: 07/20/2021] [Indexed: 11/24/2022]
Abstract
A peptide from the P0 acidic ribosomal protein (pP0) of ticks conjugated to keyhole limpet hemocyanin from Megathura crenulata has shown to be effective against different tick species when used in host vaccination. Turning this peptide into a commercial anti-tick vaccine will depend on finding the appropriate, technically and economically feasible way to present it to the host immune system. Two conjugates (p64K-Cys1pP0 and p64K-βAla1pP0) were synthesized using the p64K carrier protein from Neisseria meningitidis produced in Escherichia coli, the same cross-linking reagent, and two analogues of pP0. The SDS-PAGE analysis of p64K-Cys1pP0 showed a heterogeneous conjugate compared to p64K-βAla1pP0 that was detected as a protein band at 91kDa. The pP0/p64K ratio determined by MALDI-MS for p64K-Cys1pP0 ranged from 1 to 8, being 3-5 the predominant ratio, while in the case of p64K-βAla1pP0 this ratio was 5-7. Cys1pP0 was partially linked to 35 out of 39 Lys residues and the N-terminal end, while βAla1pP0 was mostly linked to the six free cysteine residues, to the N-terminal end, and, in a lesser extent, to Lys residues. The assignment of the conjugation sites and side reactions were based on the identification of type 2 peptides. Rabbit immunizations showed the best anti-pP0 titers and the highest efficacy against Rhipicephalus sanguineus ticks when the p64K-Cys1pP0 was used as vaccine antigen. The presence of high molecular mass aggregates observed in the SDS-PAGE analysis of p64K-Cys1pP0 could be responsible for a better immune response against pP0 and consequently for its better efficacy as an anti-tick vaccine. Graphical abstract ![]()
Collapse
|
2
|
Rodríguez-Álvarez Y, Cabrales-Rico A, Diago-Abreu D, Correa-Arguelles E, Reyes-Acosta O, Puente-Pérez P, Pichardo-Díaz D, Urquiza-Noa D, Hernández-Santana A, Garay-Pérez HE. d-Amino acid substitutions and dimerization increase the biological activity and stability of an IL-15 antagonist peptide. J Pept Sci 2020; 27:e3293. [PMID: 33331098 DOI: 10.1002/psc.3293] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2020] [Revised: 10/20/2020] [Accepted: 11/13/2020] [Indexed: 12/26/2022]
Abstract
Interleukin (IL)-15 plays an important role in several inflammatory diseases. We have previously identified an IL-15 antagonist called P8 peptide, which binds specifically to IL-15 receptor alpha subunit. However, the P8 peptide rapidly degraded by proteases, limiting its therapeutic application. Thus, we replaced each P8 peptide l-amino acid by its corresponding d-isomers. First, we determined the biological activity of the resulting peptides in a proliferation assay by using CTLL-2 cells. The substitution of l-Ala by d-Ala ([A4a]P8 peptide) increased the inhibitory effect of the P8 peptide in CTLL-2 cells in five-fold. In addition to that, the [A4a]P8 peptide dimer showed the most inhibitory effect. To protect the [A4a]P8 peptide and its dimer against exopeptidase activity, we acetylated the N-terminal of these peptides. At least a three-fold reduction in antagonist activity of acetylated peptides was exhibited. However, the substitution of the N-terminal l-Lys residue of [A4a]P8 peptide and its dimer by d-Lys ([K1k;A4a]P8 peptide) did not affect the antagonist effect of the aforementioned peptides. The [K1k;A4a]P8 peptide dimer was stable to the degradation of trypsin, chymotrypsin, and pepsin up until 48 min. Also, the safety and immunogenicity studies in healthy BALB/c mice demonstrated that the administration of this peptide did not affect the clinical parameters of the animals nor generated antipeptide antibodies. Our findings reveal that two distinct d-amino acid substitutions and dimerization increase the biological activity and stability of P8 peptide. The resulting peptide constitutes a novel IL-15 antagonist with potential applicability in inflammatory diseases.
Collapse
Affiliation(s)
| | - Ania Cabrales-Rico
- Chemistry and Physics Department, Center for Genetic Engineering and Biotechnology, Havana, Cuba
| | - David Diago-Abreu
- Chemistry and Physics Department, Center for Genetic Engineering and Biotechnology, Havana, Cuba
| | | | - Osvaldo Reyes-Acosta
- Chemistry and Physics Department, Center for Genetic Engineering and Biotechnology, Havana, Cuba
| | - Pedro Puente-Pérez
- Animal Facility Department, Center for Genetic Engineering and Biotechnology, Havana, Cuba
| | - Dagmara Pichardo-Díaz
- Animal Facility Department, Center for Genetic Engineering and Biotechnology, Havana, Cuba
| | - Dioslaida Urquiza-Noa
- Animal Facility Department, Center for Genetic Engineering and Biotechnology, Havana, Cuba
| | | | - Hilda E Garay-Pérez
- Chemistry and Physics Department, Center for Genetic Engineering and Biotechnology, Havana, Cuba
| |
Collapse
|
3
|
Espinosa Pérez R, Suárez JG, Diaz EN, Silva Rodríguez R, Caballero Menéndez E, Balaguer HD, Musacchio Lasa A. Scaling-up fermentation of Escherichia coli for production of recombinant P64k protein from Neisseria meningitidis. ELECTRON J BIOTECHN 2018. [DOI: 10.1016/j.ejbt.2018.03.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
|
4
|
A Natural Mouse Model for Neisseria Colonization. Infect Immun 2018; 86:IAI.00839-17. [PMID: 29440372 PMCID: PMC5913851 DOI: 10.1128/iai.00839-17] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2017] [Accepted: 02/08/2018] [Indexed: 02/07/2023] Open
Abstract
Commensals are important for the proper functioning of multicellular organisms. How a commensal establishes persistent colonization of its host is little understood. Studies of this aspect of microbe-host interactions are impeded by the absence of an animal model. We have developed a natural small animal model for identifying host and commensal determinants of colonization and of the elusive process of persistence. Our system couples a commensal bacterium of wild mice, Neisseria musculi, with the laboratory mouse. The pairing of a mouse commensal with its natural host circumvents issues of host restriction. Studies are performed in the absence of antibiotics, hormones, invasive procedures, or genetic manipulation of the host. A single dose of N. musculi, administered orally, leads to long-term colonization of the oral cavity and gut. All mice are healthy. Susceptibility to colonization is determined by host genetics and innate immunity. For N. musculi, colonization requires the type IV pilus. Reagents and powerful tools are readily available for manipulating the laboratory mouse, allowing easy dissection of host determinants controlling colonization resistance. N. musculi is genetically related to human-dwelling commensal and pathogenic Neisseria and encodes host interaction factors and vaccine antigens of pathogenic Neisseria. Our system provides a natural approach for studying Neisseria-host interactions and is potentially useful for vaccine efficacy studies.
Collapse
|
5
|
Lazo L, Izquierdo A, Suzarte E, Gil L, Valdés I, Marcos E, Álvarez M, Romero Y, Guzmán MG, Guillén G, Hermida Cruz L. Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus. Microbiol Immunol 2014; 58:219-26. [DOI: 10.1111/1348-0421.12140] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2013] [Revised: 01/16/2014] [Accepted: 01/25/2014] [Indexed: 01/12/2023]
Affiliation(s)
- Laura Lazo
- Vaccines Division; Center for Genetic Engineering and Biotechnology; P.O. Box 6162 Playa Havana 11 600 Cuba
| | - Alienys Izquierdo
- Virology Department; Tropical Medicine Institute “Pedro Kourí,” Pan American Health Organization/World Health Organization Collaborating Center for the Study of Dengue and its Vector; P.O. Box Marianao 13 Havana 11 600 Cuba
| | - Edith Suzarte
- Vaccines Division; Center for Genetic Engineering and Biotechnology; P.O. Box 6162 Playa Havana 11 600 Cuba
| | - Lázaro Gil
- Vaccines Division; Center for Genetic Engineering and Biotechnology; P.O. Box 6162 Playa Havana 11 600 Cuba
| | - Iris Valdés
- Vaccines Division; Center for Genetic Engineering and Biotechnology; P.O. Box 6162 Playa Havana 11 600 Cuba
| | - Ernesto Marcos
- Vaccines Division; Center for Genetic Engineering and Biotechnology; P.O. Box 6162 Playa Havana 11 600 Cuba
| | - Mayling Álvarez
- Virology Department; Tropical Medicine Institute “Pedro Kourí,” Pan American Health Organization/World Health Organization Collaborating Center for the Study of Dengue and its Vector; P.O. Box Marianao 13 Havana 11 600 Cuba
| | - Yaremis Romero
- Vaccines Division; Center for Genetic Engineering and Biotechnology; P.O. Box 6162 Playa Havana 11 600 Cuba
| | - María Guadalupe Guzmán
- Virology Department; Tropical Medicine Institute “Pedro Kourí,” Pan American Health Organization/World Health Organization Collaborating Center for the Study of Dengue and its Vector; P.O. Box Marianao 13 Havana 11 600 Cuba
| | - Gerardo Guillén
- Vaccines Division; Center for Genetic Engineering and Biotechnology; P.O. Box 6162 Playa Havana 11 600 Cuba
| | - Lisset Hermida Cruz
- Vaccines Division; Center for Genetic Engineering and Biotechnology; P.O. Box 6162 Playa Havana 11 600 Cuba
| |
Collapse
|
6
|
Garay H, Menéndez T, Cruz-Leal Y, Coizeau E, Noda J, Morera V, Guillén G, Albericio F, Reyes O. Study of various presentation forms for a peptide mimetic of Neisseria meningitidis serogroup B capsular polysaccharide. Bioconjug Chem 2010; 22:33-41. [PMID: 21141955 DOI: 10.1021/bc100299g] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The formulation of a broadly protective vaccine to prevent the serogroup B Neisseria meningitidis (MenB) disease is still an unmet medical need. We have previously reported the induction of bactericidal and protective antibodies against MenB after immunization of mice with a phage-displayed peptide named 4 L-5. This peptide mimics a capsular polysaccharide (CPS) epitope in MenB. With the aim of developing vaccine formulations that could be used in humans, we evaluate in this study various forms of presentation to the immune system of the 4 L-5 sequence, based on synthetic peptides. We synthesized the following: (i) a linear 4 L-5 peptide, (ii) a multiple antigen peptide containing four copies of the 4 L-5 sequence (named MAP), which was then dimerized, and the product named dimeric MAP, and (iii) a second multiple antigen peptide, in this case with two copies of the 4 L-5 sequence and a copy of a T-helper cell epitope of tetanus toxoid, which was then dimerized and the product named MAP-TT. The linear peptide, the MAP, and the dimeric MAP were conjugated to the carrier protein P64K by different conjugation methods. Plain antigens and antigens coupled to P64K were used to immunize BALB/c mice. Of those variants that gave immunogenic results, MAP-TT rendered the highest levels of specific antipeptide IgG antibodies and serum bactericidal activity. These results can find application in the development of meningococcal vaccine candidates and in peptide-based vaccines strategies.
Collapse
Affiliation(s)
- Hilda Garay
- Chemistry-Physics Division, Center for Genetic Engineering and Biotechnology, PO Box 6162, Havana, Cuba.
| | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Lazo L, Gil L, Lopez C, Valdes I, Marcos E, Alvarez M, Blanco A, Romero Y, Falcon V, Guzmán MG, Guillén G, Hermida L. Nucleocapsid-like particles of dengue-2 virus enhance the immune response against a recombinant protein of dengue-4 virus. Arch Virol 2010; 155:1587-95. [PMID: 20640909 DOI: 10.1007/s00705-010-0734-9] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2009] [Accepted: 06/16/2010] [Indexed: 11/25/2022]
Abstract
In this study, we evaluate in mice a novel formulation containing nucleocapsid-like particles of dengue-2 virus (recNLP) co-immunized with a chimeric protein composed of the dengue-4 envelope domain III fused twice within the meningococcal P64k protein of Neisseria meningitidis (PD24). The animals receiving the PD24-recNLP mixture showed the highest levels of antiviral antibodies. Similar results were obtained for IFNγ secretion levels, indicating a functional Th1 cellular response. Consistently, the percentage of mice surviving after viral challenge was significantly higher for those immunized with the mixture than for those inoculated with PD24 protein alone. In addition, in vivo depletion experiments demonstrated the decisive role of CD4(+) and CD8(+) cells in the protection conferred by immunization with PD24-recNLP. In conclusion, this report demonstrates for the first time the adjuvant capacity of dengue-2 virus recNLP. Additionally, the evidence presented highlights the potential of these particles for enhancing the immune response against heterologous recombinant proteins.
Collapse
Affiliation(s)
- Laura Lazo
- Vaccine Division, Center for Genetic Engineering and Biotechnology (CIGB), Havana 6, Cuba.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Guzman MG, Hermida L, Bernardo L, Ramirez R, Guillén G. Domain III of the envelope protein as a dengue vaccine target. Expert Rev Vaccines 2010; 9:137-47. [PMID: 20109025 DOI: 10.1586/erv.09.139] [Citation(s) in RCA: 96] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
A dengue vaccine should induce long-lasting, simultaneous protection to the four dengue viruses while avoiding the immune enhancement of viral infection. Domain III of the dengue envelope protein has been implicated in receptor binding, and is also the target of specific neutralizing antibodies. Domain III has emerged as a promising region for a subunit vaccine candidate. Here, we review the current state of knowledge on vaccine candidates based on domain III. Due to the results obtained concerning the immune response and protection in mice and monkeys, particular attention is paid to the chimeric protein domain III fused to p64k of Neisseria meningitidis.
Collapse
Affiliation(s)
- Maria G Guzman
- Department of Virology, PAHO/WHO Collaborating Center for the Study of Dengue and its Vector, Pedro Kouri Tropical Medicine Institute, Autopista Novia del Mediodía, Km 6, Apdo 601, Marianao 13, Havana, Cuba.
| | | | | | | | | |
Collapse
|
9
|
Priming and boosting determinants on the antibody response to an Epidermal Growth Factor-based cancer vaccine. Vaccine 2008; 26:4647-54. [DOI: 10.1016/j.vaccine.2008.07.003] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2008] [Revised: 06/23/2008] [Accepted: 07/01/2008] [Indexed: 11/19/2022]
|
10
|
Guirola M, Urquiza D, Alvarez A, Cannan-Haden L, Caballero E, Guillén G. Immunologic memory response induced by a meningococcal serogroup C conjugate vaccine using the P64k recombinant protein as carrier. ACTA ACUST UNITED AC 2006; 46:169-79. [PMID: 16487298 DOI: 10.1111/j.1574-695x.2005.00025.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
In this study, we used an adoptive lymphocyte transfer experiment to evaluate the ability of the P64k recombinant protein to recruit T-helper activity and induce immunologic memory response to the polysaccharide moiety in a meningococcal serogroup C conjugate vaccine. Adoptive transfer of splenocytes from mice immunized with the glycoconjugate conferred antipolysaccharide immunologic memory to naive recipient mice. The observed anamnestic immune response was characterized by more rapid kinetics, isotype switching from IgM to IgG and higher antipolysaccharide antibody titers compared with those reached in groups transferred with splenocytes from plain polysaccharide or phosphate-immunized mice. The memory response generated was also long lasting. Sera from mice transferred with cells from conjugate-immunized mice were the only protective in the infant rat passive protection assay, and also showed higher bactericidal titers. We demonstrated that priming the mice immune system with the glycoconjugate using the P64k protein as carrier induced a memory response to the polysaccharide, promoting a switch of the T-cell-independent response to a T-cell dependent one.
Collapse
Affiliation(s)
- María Guirola
- Vaccines Division, Centro de Ingenieria Genetica y Biotechnologia, Ciudad de La Habana, Cuba.
| | | | | | | | | | | |
Collapse
|
11
|
Carmenate T, Guirola M, Alvarez A, Canaán L, González S, Caballero E, Menéndez T, Guillén G. Memory immune response generated inCercopithecus aethiopsagainst meningococcal polysaccharide serogroup C conjugate vaccine. ACTA ACUST UNITED AC 2005; 43:133-40. [PMID: 15681142 DOI: 10.1016/j.femsim.2004.07.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2004] [Revised: 06/04/2004] [Accepted: 07/01/2004] [Indexed: 11/26/2022]
Abstract
The chemical conjugation of bacterial polysaccharide to carrier proteins has proved to be an efficient tool to improve the immunological response against these bacterial antigens. In this study, we characterized the antibody response generated in a non-human primate model against the meningococcal capsular polysaccharide serogroup C (CCPS) conjugated to the P64k protein. Similar to licensed vaccines the CCPS conjugate is able to generate a good memory immune response with antibody titers threefold higher than the free CCPS. Three different ELISA protocols were used to measure the antibody response and the importance of the coating antigen was demonstrated. The ELISA using the derivatized CCPS showed the best results and had a high correlation with the bactericidal activity. The antibodies elicited showed a high protective capacity when assayed in the infant rat protection model.
Collapse
Affiliation(s)
- T Carmenate
- Centro de Ingeniería Genética y Biotecnología, Avenue 135, P.O. Box 6162, Havana 10600, Cuba.
| | | | | | | | | | | | | | | |
Collapse
|
12
|
González S, Nazábal C, Rao KVS, Reyes O, Garay HE, Caballero E, Alvarez-Obregón JC, Sardiñas G, Silva R. Cell mediated immune response elicited in mice after immunization with the P64k meningococcal protein: epitope mapping. ACTA ACUST UNITED AC 2004; 42:233-9. [PMID: 15364109 DOI: 10.1016/j.femsim.2004.05.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2004] [Revised: 05/24/2004] [Accepted: 05/25/2004] [Indexed: 11/16/2022]
Abstract
The P64k protein of Neisseria meningitidis has been reported as an immunological carrier for weak immunogens. This investigation was aimed at characterizing the T-cell response produced in primed mice and at identifying T helper cell epitopes within this molecule. BALB/c mice subcutaneously immunized with the recombinant antigen provided inguinal lymph node cells (LNC) that proliferated in the presence of P64k in a dose-dependent manner. Proliferating cells secreted IL-4 while the concentration of IL-12 remained unaltered in the culture supernatant. By testing a panel of 59 overlapping synthetic peptides spanning the entire sequence of the antigen a T-cell determinant was localized. Prime-boost and lymphoproliferation experiments, conducted with highly purified synthetic peptides, confirmed that the segment including amino acids 470-485 comprises a T-cell epitope within the P64k molecule.
Collapse
Affiliation(s)
- Sonia González
- Center for Genetic Engineering and Biotechnology, P.O. Box 6162, Havana 10600, Cuba.
| | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Carmenate T, Canaán L, Alvarez A, Delgado M, González S, Menéndez T, Rodés L, Guillén G. Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide-P64k protein conjugates. ACTA ACUST UNITED AC 2004; 40:193-9. [PMID: 15039094 DOI: 10.1016/s0928-8244(03)00346-8] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2002] [Revised: 06/27/2003] [Accepted: 10/30/2003] [Indexed: 10/26/2022]
Abstract
Neisseria meningitidis serogroup C polysaccharide (CCPS) was conjugated to the carrier protein P64k using two different conjugation procedures, condensation mediated by carbodiimide with adipic acid dihydrazide as spacer and the reductive amination method. BALB/c mice were immunized with the resultant polysaccharide-protein conjugates and the immune response was evaluated. All conjugates assayed generated at least 10-fold higher antibody titers than the free polysaccharide. The reductive amination method rendered the best conjugate (CCPS-P64kR) that was able to elicit antibody titers statistically higher than the titer elicited by the plain CCPS (P<0.001). The sera of the group immunized with CCPS-P64kR showed a three-fold higher bactericidal response than the sera of the group immunized with the plain CCPS and they were able to protect against challenge with meningococci in the infant rat protection model. In addition, three different conjugates were obtained from polysaccharides with molecular relative sizes of 2000-4000 Da, 4000-10,000 Da or 10,000-50,000 Da, but no differences were detected in the immune response obtained against the three conjugates. Our experiments demonstrate that it is possible to generate a protective, T-cell-dependent response against CCPS using the P64k protein as carrier.
Collapse
MESH Headings
- Adipates
- Amination
- Animals
- Antibodies, Bacterial/blood
- Bacterial Outer Membrane Proteins/chemistry
- Bacterial Outer Membrane Proteins/immunology
- Carbodiimides
- Colony Count, Microbial
- Disease Models, Animal
- Immunoglobulin G/blood
- Meningococcal Infections/immunology
- Meningococcal Infections/prevention & control
- Meningococcal Vaccines/chemistry
- Meningococcal Vaccines/immunology
- Mice
- Mice, Inbred BALB C
- Molecular Weight
- Neisseria meningitidis, Serogroup C/growth & development
- Neisseria meningitidis, Serogroup C/immunology
- Polysaccharides, Bacterial/chemistry
- Polysaccharides, Bacterial/immunology
- Rats
- Vaccines, Conjugate/chemistry
- Vaccines, Conjugate/immunology
Collapse
Affiliation(s)
- Tania Carmenate
- Centre for Genetic Engineering and Biotechnology, Division of Vaccines, PO Box 6162, Havana 6, Cuba.
| | | | | | | | | | | | | | | |
Collapse
|
14
|
Tozawa K, Broadhurst RW, Raine AR, Fuller C, Alvarez A, Guillen G, Padron G, Perham RN. Solution structure of the lipoyl domain of the chimeric dihydrolipoyl dehydrogenase P64K from Neisseria meningitidis. EUROPEAN JOURNAL OF BIOCHEMISTRY 2001; 268:4908-17. [PMID: 11559360 DOI: 10.1046/j.0014-2956.2001.02422.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The antigenic P64K protein from the pathogenic bacterium Neisseria meningitidis is found in the outer membrane of the cell, and consists of two parts: an 81-residue N-terminal region and a 482-residue C-terminal region. The amino-acid sequence of the N-terminal region is homologous with the lipoyl domains of the dihydrolipoyl acyltransferase (E2) components, and that of the C-terminal region with the dihydrolipoyl dehydrogenase (E3) components, of 2-oxo acid dehydrogenase multienzyme complexes. The two parts are separated by a long linker region, similar to the linker regions in the E2 chains of 2-oxo acid dehydrogenase complexes, and it is likely this region is conformationally flexible. A subgene encoding the P64K lipoyl domain was created and over-expressed in Escherichia coli. The product was capable of post-translational modification by the lipoate protein ligase but not aberrant modification by the biotin protein ligase of E. coli. The solution structure of the apo-domain was determined by means of heteronuclear NMR spectroscopy and found to be a flattened beta barrel composed of two four-stranded antiparallel beta sheets. The lysine residue that becomes lipoylated is in an exposed beta turn that, from a [1H]-15N heteronuclear Overhauser effect experiment, appears to enjoy substantial local motion. This structure of a lipoyl domain derived from a dihydrolipoyl dehydrogenase resembles that of lipoyl domains normally found as part of the dihydrolipoyl acyltransferase component of 2-oxo acid dehydrogenase complexes and will assist in furthering the understanding of its function in a multienzyme complex and in the membrane-bound P64K protein itself.
Collapse
Affiliation(s)
- K Tozawa
- Cambridge Centre for Molecular Recognition, Department of Biochemistry, University of Cambridge, UK
| | | | | | | | | | | | | | | |
Collapse
|
15
|
González S, Caballero E, Silva R, Pajón R. Effect of P64k presensitization on its efficacy as an immunological carrier in mice. Biochem Biophys Res Commun 2001; 282:376-9. [PMID: 11401468 DOI: 10.1006/bbrc.2001.4581] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Recently, we have successfully employed the meningococcal P64k protein as a carrier for weak immunogens. Here, we study if presensitization with it can affect the murine antibody response against the hapten chemically coupled to P64k. We found that priming with 10 microg of P64k did not induce epitope-specific suppression against two out of three synthetic peptides, from viral proteins, conjugated to this carrier. Depending on the anti-carrier antibody titers elicited in the presensitized mice, we observed or not a suppressed immune response against the third peptide. Presensitization with 100 microg of P64k resulted in epitope-specific suppression when lower doses of conjugate were administered. In summary, as described for other protein carriers, P64k could induce epitope-specific suppression in mice, but it depends on the hapten and the extent of carrier-specific immunity. Furthermore, this suppression can be overcome by increasing the amount of conjugate administered per dose in the presensitized animals.
Collapse
Affiliation(s)
- S González
- División de Vacunas, Centro de Ingeniería Genética y Biotecnología, Ciudad Havana CP, 10600, Cuba.
| | | | | | | |
Collapse
|
16
|
Nazábal C, Carmenate T, Cruz S, González S, Silva R, Musacchio A, Delgado M, Chinea G. Mapping of monoclonal antibodies specific to P64k: A common antigen of several isolates of Neisseria meningitidis. Can J Microbiol 2001. [DOI: 10.1139/w00-133] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
P64k is a minor outer membrane protein from Neisseria meningitidis. This protein has been produced at high levels in Escherichia coli. We generated a group of monoclonal antibodies (mAbs) against recombinant P64k, which recognise four non-overlapping epitopes, as shown using competition assays with biotinylated mAbs. The P64k sequences involved in mAbs binding were mapped with synthetic overlapping peptides derived from the P64k protein, and located in the previously determined three-dimensional structure of the protein. These antibodies were also characterised by whole-cell ELISA and bactericidal tests against N. meningitidis. Only two of the recognised epitopes were exposed on the bacterial surface, and none of the mAbs showed bactericidal activity. The relationship between these results and the structural data on the epitopes bound by the mAbs is discussed.Key words: Neisseria meningitidis, P64k, monoclonal antibodies, epitope mapping.
Collapse
|
17
|
Sardiñas G, González S, Garay HE, Nazábal C, Reyes O, Silva R. Anti-PorA antibodies elicited by immunization with peptides conjugated to P64k. Biochem Biophys Res Commun 2000; 277:51-4. [PMID: 11027638 DOI: 10.1006/bbrc.2000.3623] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
To increase the humoral immune response against two cyclic synthetic peptides, derived from variable regions within the outer membrane meningococcal protein PorA (subtypes 19 and 15), we conjugated the peptides to P64k, a novel carrier protein from the same bacterium expressed in Escherichia coli. In addition, one of these peptides was restricted to a linear conformation before it was chemically coupled to the carrier. The conjugates were administered to mice in a three-dose immunization schedule, resulting in a potent anti-peptide immune response, which suggested that chemical conjugation to this carrier provided T-cell help. Antisera directed to the three conjugates reacted with Neisseria meningitidis outer membrane PorA upon immunoblot analysis. Moreover, in two out of three conjugates, the anti-peptide sera reacted with native meningococcal outer membrane vesicles in ELISA.
Collapse
Affiliation(s)
- G Sardiñas
- División de Vacunas, Centro de Ingeniería Genética y Biotecnología, Havana, CP 10600, Cuba
| | | | | | | | | | | |
Collapse
|